Intragraft gene expression profile associated with the induction of tolerance by allochimeric MHC I in the rat heart transplantation model

Genesis

Volumn 48, Issue 1, 2010, Pages 8-19

  Lisik, Wojciech ^a   Gong, Yongquan ^b   Tejpal, Neelam ^b   Skelton, Thomas S ^b   Bremer, Eric G ^c   Kloc, Malgorzata ^b   Ghobrial, Rafik M ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Precision Biomarker Resources   (United States)

Author keywords

Allochimeric MHC; Heart allograft; MHC I; Transplantation

Indexed keywords

ALLOANTIGEN; CYCLOSPORIN; CYTOKINE; EPITOPE; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUTANT PROTEIN; PROTEIN; PROTEIN PAR6; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CELL MOTILITY; CELL POLARITY; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE INDUCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CYCLOSPORINE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION TOLERANCE;

RATTUS;

EID: 74749108895     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20574     Document Type: Article

References (48)

1. Arstall MA, Sawyer DB, Fukazawa R, Kelly RA. 1999. Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible NO synthase induction and peroxynitrite generation. Circ Res 85:829-840.
2. Batten P, Yacoub MH, Rose ML. 1996. Effect of human cytokines (IFNgamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Immunology 87:127-133.
3. Bers DM. 2006. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21:380-387.
4. Bick RJ, Liao JP, King TW, LeMaistre A, McMillin JB, Buja LM. 1997. Temporal effects of cytokines on neonatal cardiac myocyte Ca2+ transients and adenylate cyclase activity. Am J Physiol 41:H1937-H1944.
5. Butcher GW, Howard JC. 1982. Genetic control of transplant rejection. Transplantation 34:161-166.
6. Chevrel G, Garnero P, Miossec P. 2002. Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation. Ann Rheum Dis 61:730-733.
7. Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, Robinson TE, Dearlove AM, Ribas G, Bonser AJ, Thomas NR, Scotter AJ, Caves LS, Tyrrell GP, Newbury-Ecob RA, Munnich A, Bonnet D, Brook JD. 2005. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 37:423-428.
8. Colovai AI, Renna-Molajoni E, Cortesini R, Suciu-Foca N. 1996. New approaches to specific immunomodulation in transplantation. Int Rev Immunol 13:161-172.
9. Dunn DL. 1990. Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation. Crit Care Clin 6:955-977.
10. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol, in press.
11. Flavigny J, Richard P, Isnard R, Carrier L, Charron P, Bonne G, Forissier JF, Desnos M, Dubourg O, Komajda M, Schwartz K, Hainque B. 1998. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med 76:208-214.
12. Ghobrial RM, Hamashima T, Wang M, Stepkowski SM, Kahan BD. 1996. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules. Transplantation 62:1002-1010.
13. Hausmann R, Zavazava N, Steinmann J, Muller-Ruchholtz W. 1993. Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTC). Clin Exp Immunol 91:183-188.
14. Hilal-Dandan R, He H, Martin JL, Brunton LL, Dillmann WH. 2009. Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: Regulation by pertussis toxin-sensitive gi protein and cAMP. Am J Physiol Heart Circ Physiol 296:H728-H734.
15. Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH. 1999. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 84:21-33.
16. Kacimi R, Karliner JS, Koudssi F, Long CS. 1998. Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia. Circ Res 82:576-586.
17. Kim SK. 2000. Cell polarity: New PARtners for Cdc42 and Rac. Nat Cell Biol 2:E143-E145.
18. Li J, Xiao M. 2001. Relationship between expression of IL-1 beta mRNA and rejection of heart allograft. Zhonghua Wai Ke Za Zhi 39:882-884.
19. Libby P, Warner SJC, Friedman GB. 1988. Interleukin-1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81:487-498.
20. Long CS. 2001. The role of interleukin-1 in the failing heart. Heart Fail Rev 6:81-94.
21. Loppnow H, Libby P. 1989. Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL-1. Cell Immunol 122:493-503.
22. Loppnow H, Libby P. 1990. Proliferating or interleukin-1-activated human vascular smooth muscle cells secrete copious interleukin-6. J Clin Invest 85:731-738.
23. Loppnow H, Werdan K, Reuter G, Flad H-D. 1998. The interleukin-1 and interleukin-1-converting enzyme families in the cardiovascular system. Eur Cytokine Netw 9:675-680.
24. Macara IG. 2004. Parsing the polarity code. Nat Rev Mol Cell Biol 5:220-231.
25. Mountain DJ, Singh M, Singh K. 2008. Interleukin-1beta-mediated inhibition of the processes of angiogenesis in cardiac microvascular endothelial cells. Life Sci 82:1224-1230.
26. Müller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K. 1998. Endotoxin and tumor necrosis factor-α exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol 30:1027-1036.
27. Neckelmann N, Warner CK, Chung A, Kudoh J, Minoshima S, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Liu JD. 1989. The human ATP synthase beta subunit gene: Sequence analysis, chromosome assignment, and differential expression. Genomics 5:829-843.
28. Ohtsuka T, Nakanishi H, Ikeda W, Satoh A, Momose Y, Nishioka H, Takai Y. 1998. Nexilin: A novel actin filament-binding protein localized at cell-matrix adherens junction. J Cell Biol 143:1227.
29. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. 1998. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98:149-156.
30. Ozeren A, Aydin M, Tokac M, Demircan N, Unalacak M, Gurel A, et al. 2003. Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators Inflamm 12:361-365.
31. Real E, Faure S, Donnadieu E, Deln J. 2007. Cutting edge: Atypical PKCs regulate T lymphocyte polarity and scanning behavior. J Immunol 179:5649-5652.
32. Saiura A, Mataki C, Murakami T, Umetani M, Wada Y, Kohro T, Aburatani H, Harihara Y, Hamakubo T, Yamaguchi T, Hasegawa G, Naito M, Makuuchi M, Kodama T. 2001. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 72:320-329.
33. Sayegh MH, Carpenter CB. 1996. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 13:221-229.
34. Semiltova N, Shen XD, Fishbein MC, Gao F, Slomowitz SJ, Jiao Q, Mukherjee K, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. 2003. Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance. Transplantation 75:550-553.
35. Semiletova NV, Shen XD, Baibakov B, Feldman DM, Mukherjee K, Frank JM, Stepkowski SM, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. 2005. Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts. Transplantation 80:1535-1340.
36. Seo GM, Jung KH, Kim SJ, Kim JC, Yoon JW, Oh KK, Lee JH, Chai YG. 2008. Bacillus anthracis spores influence ATP synthase activity in murine macrophages. J Microbiol Biotechnol 18:778-783.
37. Singer JS, Mhoyan A, Fishbein MC, Shen XD, Gao F, Zhao D, Coito AJ, Reemtsen BL, Amersi F, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM. 2001. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses. Transplantation 72: 1408-1416.
38. Tardiff JC. 2004. Myosin at the Heart of the Problem. N Engl J Med 351:424-426.
39. Tomita M, Dragoman M, Worcester H, Conran P, Santoro TJ. 2004. Proinflammatory cytokine genes are constitutively overexpressed in the heart in experimental systemic lupus erythematosus: A brief communication. Exp Biol Med (Maywood) 229:971-976.
40. Trivedi HL. 2007. Immunobiology of rejection and adaptation. Trans Proc 39:647-652.
41. Ukimura A, Terasaki F, Fujioka S, Deguchi H, Kitaura Y, Isomura T, Suma H. 2003. Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM). J Card Surg 18 (Suppl 2):S101-S108.
42. Wang Z, Wang DZ, Pipes GC, Olson EN. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100:7129-7134.
43. Wang W, Zhang W, Han Y, Chen J, Wang Y, Zhang Z, Hui R. 2005. NELIN, a new F-actin associated protein, stimulates HeLa cell migration and adhesion. Biochem Biophys Res Commun 330:1127-1138.
44. Westphal E, Rohrbach S, Buerke M, Behr H, Darmer D, Silber RE, Werdan K, Loppnow H. 2008. Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy. Mol Med 14:55-63.
45. Xia HF, Peng JP, Sun QH, Yang Y, Liu ML. 2006. Effects of IL-1 beta on RT1-A/RT1-DM at the maternal-fetal interface during pregnancy in rats. Front Biosci 11:2868-2875.
46. Zavazava N, Kronke M. 1996. Soluble HLA class I molecules induce apoptosis in alloreative cytotoxic T lymphocytes. Nat Med 2:1005-1010.
47. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN. 2005. High-Throughput GoMiner, an 'industrial-strength' integrative Gene Ontology tool for interpretation of multiplemicroarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6:168.
48. Zhao Y, Wei YJ, Cao HQ, Ding JF. 2001. Molecular cloning of NELIN, a putative human cytoskeleton regulation gene. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33:19-24.